These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28450298)

  • 1. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.
    Vazquez-Prada KX; Lam J; Kamato D; Xu ZP; Little PJ; Ta HT
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):601-613. PubMed ID: 33356385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI, the technology for imaging of thrombi and inflammation.
    von Zur Muhlen C; Bode C
    Hamostaseologie; 2015; 35(3):252-62. PubMed ID: 25634650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy.
    Hartley A; Haskard D; Khamis R
    Trends Cardiovasc Med; 2019 Jan; 29(1):22-26. PubMed ID: 29934015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
    Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
    Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
    McAteer MA; Choudhury RP
    Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques.
    Htun NM; Chen YC; Lim B; Schiller T; Maghzal GJ; Huang AL; Elgass KD; Rivera J; Schneider HG; Wood BR; Stocker R; Peter K
    Nat Commun; 2017 Jul; 8(1):75. PubMed ID: 28706202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of atherosclerosis: can molecular imaging do more?
    Lairez O; Fayad ZA
    Arch Cardiovasc Dis; 2013 Nov; 106(11):551-3. PubMed ID: 23927996
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
    J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of arterial and venous thrombosis.
    Wang X; Ziegler M; McFadyen JD; Peter K
    Br J Pharmacol; 2021 Nov; 178(21):4246-4269. PubMed ID: 34296431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.
    Gargiulo S; Gramanzini M; Mancini M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of atherosclerosis.
    Takx RA; Partovi S; Ghoshhajra BB
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):5-12. PubMed ID: 26239134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Elastase for Molecular Imaging of Early Atherosclerotic Lesions.
    Glinzer A; Ma X; Prakash J; Kimm MA; Lohöfer F; Kosanke K; Pelisek J; Thon MP; Vorlova S; Heinze KG; Eckstein HH; Gee MW; Ntziachristos V; Zernecke A; Wildgruber M
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):525-533. PubMed ID: 28062502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.